194 related articles for article (PubMed ID: 34091389)
21. Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors.
Cani AK; Hovelson DH; McDaniel AS; Sadis S; Haller MJ; Yadati V; Amin AM; Bratley J; Bandla S; Williams PD; Rhodes K; Liu CJ; Quist MJ; Rhodes DR; Grasso CS; Kleer CG; Tomlins SA
Mol Cancer Res; 2015 Apr; 13(4):613-9. PubMed ID: 25593300
[TBL] [Abstract][Full Text] [Related]
22. Malignant phyllodes tumor with liposarcomatous differentiation.
Isotalo PA; George RL; Walker R; Sengupta SK
Arch Pathol Lab Med; 2005 Mar; 129(3):421-2. PubMed ID: 15737047
[No Abstract] [Full Text] [Related]
23. Cystosarcoma phyllodes with liposarcomatous stroma in the female breast.
Galler L; Beach RJ
N J Med; 1986 Apr; 83(4):243-5. PubMed ID: 3012423
[No Abstract] [Full Text] [Related]
24. Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosis.
Pfarr N; Kriegsmann M; Sinn P; Klauschen F; Endris V; Herpel E; Muckenhuber A; Jesinghaus M; Klosterhalfen B; Penzel R; Lennerz JK; Weichert W; Stenzinger A
Genes Chromosomes Cancer; 2015 Jul; 54(7):444-52. PubMed ID: 25931199
[TBL] [Abstract][Full Text] [Related]
25. [Malignant phyllodes tumor of the breast with liposarcomatous differentiation. Solution to case 40].
Nieto Parra JA; Domínguez Pérez AD; Vieites Pérez-Quintela MB; Fal Ordoñez MA
Radiologia; 2012; 54(2):190-2. PubMed ID: 21733534
[No Abstract] [Full Text] [Related]
26. Periductal Stromal Tumor of the Breast with a
Anderson B; Marotti JD; Lefferts JA; Muller KE
Int J Surg Pathol; 2023 Dec; 31(8):1626-1631. PubMed ID: 36823780
[TBL] [Abstract][Full Text] [Related]
27. [Malignant phyllodes tumor with liposarcomatous differentiation. Description of a clinical case].
Scala M; Mereu P; Comandini D; Nocentini L; Vecchio C
Minerva Chir; 1999 May; 54(5):355-8. PubMed ID: 10443117
[TBL] [Abstract][Full Text] [Related]
28. MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways.
Laé M; Gardrat S; Rondeau S; Richardot C; Caly M; Chemlali W; Vacher S; Couturier J; Mariani O; Terrier P; Bièche I
Oncotarget; 2016 Dec; 7(51):84428-84438. PubMed ID: 27806318
[TBL] [Abstract][Full Text] [Related]
29. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
30. Liposarcoma arising within a cystosarcoma phyllodes.
Jimenez JF; Gloster ES; Perrot LJ; Mollitt DL; Gollady ES
J Surg Oncol; 1986 Apr; 31(4):294-8. PubMed ID: 3014222
[TBL] [Abstract][Full Text] [Related]
31. Phyllodes tumors of the breast segregate in two groups according to genetic criteria.
Laé M; Vincent-Salomon A; Savignoni A; Huon I; Fréneaux P; Sigal-Zafrani B; Aurias A; Sastre-Garau X; Couturier J
Mod Pathol; 2007 Apr; 20(4):435-44. PubMed ID: 17334353
[TBL] [Abstract][Full Text] [Related]
32. Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression.
Piscuoglio S; Ng CK; Murray M; Burke KA; Edelweiss M; Geyer FC; Macedo GS; Inagaki A; Papanastasiou AD; Martelotto LG; Marchio C; Lim RS; Ioris RA; Nahar PK; Bruijn ID; Smyth L; Akram M; Ross D; Petrini JH; Norton L; Solit DB; Baselga J; Brogi E; Ladanyi M; Weigelt B; Reis-Filho JS
J Pathol; 2016 Mar; 238(4):508-18. PubMed ID: 26832993
[TBL] [Abstract][Full Text] [Related]
33. Malignant phyllodes tumor of a genotypic male, phenotypic female with liposarcomatous differentiation.
Lee JW; Nadelman CM; Hirschowitz SL; Debruhl ND; Bassett LW
Breast J; 2007; 13(3):312-3. PubMed ID: 17461912
[No Abstract] [Full Text] [Related]
34. Malignant phyllodes tumor with associated osteosarcomatous, chondrosarcomatous, and liposarcomatous overgrowth.
Tomas D; Bujas T; Stajduhar E; Kirac P; Mijić A; Kruslin B
APMIS; 2007 Apr; 115(4):367-70. PubMed ID: 17504305
[No Abstract] [Full Text] [Related]
35. Metaplastic Breast Cancer Masquerading as Liposarcoma of the Breast: A Case Report following Oncoplastic Treatment.
Elghobashy M; Basu N; Warner R; Dickson J; Shaaban AM
Pathobiology; 2018; 85(4):261-265. PubMed ID: 29788010
[TBL] [Abstract][Full Text] [Related]
36. Frequent MED12 mutations in phyllodes tumours of the breast.
Yoshida M; Sekine S; Ogawa R; Yoshida H; Maeshima A; Kanai Y; Kinoshita T; Ochiai A
Br J Cancer; 2015 May; 112(10):1703-8. PubMed ID: 25839987
[TBL] [Abstract][Full Text] [Related]
37. MED12 exon 2 mutations in phyllodes tumors of the breast.
Nagasawa S; Maeda I; Fukuda T; Wu W; Hayami R; Kojima Y; Tsugawa K; Ohta T
Cancer Med; 2015 Jul; 4(7):1117-21. PubMed ID: 25865354
[TBL] [Abstract][Full Text] [Related]
38. Phyllodes Tumor of the Breast With Malignant Melanoma Component: A Case Report.
Vergine M; Guy C; Taylor MR
Int J Surg Pathol; 2015 Sep; 23(6):483-8. PubMed ID: 26113664
[TBL] [Abstract][Full Text] [Related]
39. Genomic characterisation of breast fibroepithelial lesions in an international cohort.
Md Nasir ND; Ng CCY; Rajasegaran V; Wong SF; Liu W; Ng GXP; Lee JY; Guan P; Lim JQ; Thike AA; Koh VCY; Loke BN; Chang KTE; Gudi MA; Lian DWQ; Madhukumar P; Tan BKT; Tan VKM; Wong CY; Yong WS; Ho GH; Ong KW; ; Tan P; Teh BT; Tan PH
J Pathol; 2019 Dec; 249(4):447-460. PubMed ID: 31411343
[TBL] [Abstract][Full Text] [Related]
40. Lipomatous tumors of the breast: A contemporary review.
Rowe JJ; Cheah AL; Calhoun BC
Semin Diagn Pathol; 2017 Sep; 34(5):453-461. PubMed ID: 28662999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
